About this trial

This is an international, multicenter, observational study aimed at investigating acute kidney injury requiring renal replacement therapy (AKI-RRT) in Latin American countries. The main questions this study aims to answer are:

* What is the epidemiology, outcomes, and processes of care for patients with AKI-RRT in Latin America? * How do outcomes differ across different countries in Latin America? * What factors (demographics, clinical, socioeconomic) influence outcomes in patients with AKI-RRT in Latin America?

The main aims of this study are to:

* Establish a comprehensive database containing clinical, laboratory, treatment, process, and outcome data of patients with AKI-RRT in Latin America * Describe current epidemiology of AKI-RRT in Latin America * Compare processes of care and outcomes across different countries in Latin America * Provide data resources to facilitate and promote clinical research in AKI-RRT

Eligibility criteria

Qualifiers

Adult patient (≥18) admitted to the ICU

First ICU admission during current hospitalization

Diagnosis of acute kidney injury stage 3 according to KDIGO guidelines

RRT initiated no earlier than 3 days before or no later than 7 days after ICU admission

Disqualifiers

Transfer from outside hospital with ongoing RRT

RRT exposure of less than 2 days (if CRRT or PD was provided) or less than 2 HD/SLED sessions

Kidney failure (ESRD) patients on maintenance dialysis

Kidney transplant recipients

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

1,000 Participants
are grouped into 1 trial group

Locations

15
Bolivia
Hospital Obrero No 2 Cochabamba Bolivia
Brazil
Ana Nery Hospital Bahia Brazil
Hospital Sao Lucas da PUCRS Porto Alegre Brazil
Hospital das Clínicas da Universidade de São Paulo São Paulo Brazil

Sponsors and collaborators

University of Alabama at Birmingham

Lead sponsor

Vantive Health LLC

Collaborator